v3.26.3
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit) - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Stock Subscription Receivable
Total
Balance at Dec. 31, 2024 $ 13,169 $ 101,998,956 $ (122,368,539) $ (2,545,586) $ (22,902,000)
Balance (in Shares) at Dec. 31, 2024 2,633,956        
Balance at Dec. 31, 2024 $ 13,169 101,998,956 (122,368,539) (2,545,586) (22,902,000)
Balance (in Shares) at Dec. 31, 2024 2,633,956        
Shares issued from exercise of Series A Warrants $ 90 671,478 671,568
Shares issued from exercise of Series A Warrants (in Shares) 172,287        
Conversion of convertible notes into common stock $ 339 527,161 527,500
Conversion of convertible notes into common stock (in Shares) 68,095        
Shares issued to consultants $ 1 670 671
Shares issued to consultants (in Shares) 100        
Reverse stock split $ (13,311) 12,851 (460)
Reverse stock split (in Shares) (112)        
Stock-based compensation to employees and directors 1,307,095 1,307,095
Net Income (Loss) 2,988,626 2,988,626
Balance at Sep. 30, 2025 $ 288 104,518,211 (119,379,913) (2,545,586) (17,407,000)
Balance (in Shares) at Sep. 30, 2025 2,874,326        
Balance at Jun. 30, 2025 $ 272 103,738,980 (115,287,768) (2,545,586) (14,094,102)
Balance (in Shares) at Jun. 30, 2025 2,716,794        
Shares issued from exercise of Series A Warrants $ 16 430,006 430,022
Shares issued from exercise of Series A Warrants (in Shares) 157,532        
Stock-based compensation to employees and directors 349,225 349,225
Net Income (Loss) (4,092,145) (4,092,145)
Balance at Sep. 30, 2025 $ 288 104,518,211 (119,379,913) (2,545,586) (17,407,000)
Balance (in Shares) at Sep. 30, 2025 2,874,326        
Balance at Dec. 31, 2025 $ 746 159,027,646 (163,372,539) (2,841,427) (7,185,574)
Balance (in Shares) at Dec. 31, 2025 7,465,283        
Shares issued upon settlement of warrants $ 24 (24)
Shares issued upon settlement of warrants (in Shares) 240,400        
Shares issued from exercise of Series A Warrants $ 2 357,139 357,141
Shares issued from exercise of Series A Warrants (in Shares) 17,088        
Shares issued from exercise of Series A Warrants – related party $ 21 1,667,327 1,667,348
Shares issued from exercise of Series A Warrants – related party (in Shares) 214,037        
Forward Purchase Agreement – subscription receivable discount 236,798 (236,798)
Discount on short term notes payable 70,000 70,000
Private Placement - Issuance of common stock, net of issuance costs $ 75 9,721,983 9,722,058
Private Placement - Issuance of common stock, net of issuance costs (in Shares) 750,000        
Private Placement - Issuance of pre-funded stock purchase warrants, net of issuance costs 20,520,023 20,520,023
Issuance of stock purchase warrants 1,938,014 1,938,014
Cancellation of Forward Purchase Agreement (3,078,225) 3,078,225
Repurchase and cancellation of shares – related party $ (2) (140,000) (140,002)
Repurchase and cancellation of shares – related party (in Shares) (19,915)        
Exercise of prefunded warrants $ 28 28
Exercise of prefunded warrants (in Shares) 275,000        
Stock-based compensation to employees and directors 879,492 879,492
Stock-based compensation to consultants $ 4 (4)    
Stock-based compensation to consultants (in Shares) 40,000        
Net Income (Loss) (4,073,001) (4,073,001)
Balance at Sep. 30, 2026 $ 898 191,200,169 (167,445,540) 23,755,527
Balance (in Shares) at Sep. 30, 2026 8,981,893        
Balance at Jun. 30, 2026 $ 851 192,365,464 (167,689,963) (3,001,045) 21,675,307
Balance (in Shares) at Jun. 30, 2026 8,512,771        
Shares issued from exercise of Series A Warrants – related party $ 21 1,667,327 1,667,348
Shares issued from exercise of Series A Warrants – related party (in Shares) 214,037        
Forward Purchase Agreement – subscription receivable discount 77,180 (77,180)
Cancellation of Forward Purchase Agreement (3,078,225) 3,078,225
Repurchase and cancellation of shares – related party $ (2) (140,000) $ (140,002)
Repurchase and cancellation of shares – related party (in Shares) (19,915)       19,915
Exercise of prefunded warrants $ 28 $ 28
Exercise of prefunded warrants (in Shares) 275,000        
Stock-based compensation to employees and directors 308,423 308,423
Net Income (Loss) 244,423 244,423
Balance at Sep. 30, 2026 $ 898 $ 191,200,169 $ (167,445,540) $ 23,755,527
Balance (in Shares) at Sep. 30, 2026 8,981,893